Literature DB >> 16930659

Experimental immunization with Thalassophryne nattereri fish venom: striking IL-5 production and impaired of B220+ cells.

Lidiane Zito Grund1, Valdenia Maria Oliveira Souza, Eliana Lima Faquim-Mauro, Carla Lima, Monica Lopes-Ferreira.   

Abstract

Murine experimental model have been useful to understanding the toxic as well as the pharmacological properties of the Thalassophryne nattereri venom. However, the specific immune response to T. nattereri venom in mice is yet unclear. Our results showed that the venom elicited in BALB/c mice high levels of specific IgG1 and total IgE isotype with high affinity, accompanied by a striking IL-5 production, what point out to a Th2-like response. Meanwhile, the production of IFN-gamma by lymphocytes pool expanded upon mitogen stimulus, suggests that the venom was also able to activate Th1 clones. Elevated number of antigen-presenting cells expressing CD11c or CD11b from day 4 to 6 supported ongoing antigen presentation process in the primary response and efficient T-cell expansion (increase of CD4(+) cells). In contrast, decreased B220 expression was observed, suggesting that the formation of memory long lived cell compartment. In conclusion, T. natterri venom stimulates an association of cytokine of both Th1 and Th2 profile, with a notable IL-5 production and specific IgG1 and total IgE isotypes secretion. Furthermore, our finding showed that T. natterri venom can affect the B cell fate and induce a memory antibody response through the secretion of protective IgG subclasses. Further studies with the venom protein toxins may provide clues to molecular mechanism regulating proliferation and differentiation of antibody-secreting cells in our model. A better understating of how T. natterri venom can modulate immune response could be useful in therapeutic strategies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16930659     DOI: 10.1016/j.toxicon.2006.06.014

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  7 in total

Review 1.  Bioactive components in fish venoms.

Authors:  Rebekah Ziegman; Paul Alewood
Journal:  Toxins (Basel)       Date:  2015-04-30       Impact factor: 4.546

2.  The hierarchical process of differentiation of long-lived antibody-secreting cells is dependent on integrated signals derived from antigen and IL-17A.

Authors:  Lidiane Zito Grund; Monica Lopes-Ferreira; Carla Lima
Journal:  PLoS One       Date:  2013-09-18       Impact factor: 3.240

Review 3.  Thalassophryne nattereri fish venom: from the envenoming to the understanding of the immune system.

Authors:  Monica Lopes-Ferreira; Lidiane Zito Grund; Carla Lima
Journal:  J Venom Anim Toxins Incl Trop Dis       Date:  2014-08-13

4.  The longevity of Th2 humoral response induced by proteases natterins requires the participation of long-lasting innate-like B cells and plasma cells in spleen.

Authors:  Evilin Naname Komegae; Lidiane Zito Grund; Monica Lopes-Ferreira; Carla Lima
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

5.  TLR2, TLR4 and the MyD88 signaling are crucial for the in vivo generation and the longevity of long-lived antibody-secreting cells.

Authors:  Evilin Naname Komegae; Lidiane Zito Grund; Monica Lopes-Ferreira; Carla Lima
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

6.  Anaphylaxis induced by Thalassophryne nattereri venom in mice is an IgE/IgG1-mediated, IL-4-dependent phenomenon.

Authors:  Fernanda Miriane Bruni; Erica Maria Martins Coutinho; Aline Ingrid Andrade-Barros; Lidiane Zito Grund; Monica Lopes-Ferreira; Carla Lima
Journal:  Sci Rep       Date:  2020-01-17       Impact factor: 4.379

7.  Molecular Characterization and Functional Analysis of the Nattectin-like Toxin from the Venomous Fish Thalassophryne maculosa.

Authors:  Monica Lopes-Ferreira; Ines Sosa-Rosales; Pedro Ismael Silva Junior; Katia Conceicao; Adolfo Luis Almeida Maleski; Leticia Balan-Lima; Geonildo Rodrigo Disner; Carla Lima
Journal:  Toxins (Basel)       Date:  2021-12-21       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.